Financials
- Market Capitalization 1.82 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-25.35
売上高対価格比率
26.85
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2065 | VIR Vir Biotechnology, Inc. - Common Stock | 10.83 USD | -4.24% | +11.19% | +25.78% | +81.10% | 1.83 B USD | ||
| 2070 | INBX Inhibrx Biosciences, Inc. - Common Stock | 123.41 USD | -0.42% | +17.53% | +52.34% | +53.15% | 1.82 B USD | ||
| 2076 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.87 USD | -1.83% | +2.14% | +17.97% | -6.20% | 1.80 B USD | ||
| 2083 | FTRE Fortrea Holdings Inc. - Common Stock | 18.81 USD | -0.27% | +3.69% | -8.06% | +95.12% | 1.79 B USD |